Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JY09

NCT04354090 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: JY09

Sponsor

Beijing Dongfang Biotech Co., Ltd.